• FilmArray Respiratory Panel

FilmArray™ Respiratory Panel

Respiratory Panel for FilmArray™ multiplex PCR system

The FilmArray™ Respiratory Panel enables rapid and accurate automated detection of pathogens behind respiratory infections. It tests for 17 viruses and 3 bacteria which cause upper respiratory tract infections with an overall sensitivity and specificity of 95% and 99% respectively.

  • Simple: 2 minutes of hands-on time
  • Easy: No precise measuring or pipetting required
  • Fast: Turnaround time of about an hour
  • Comprehensive: 20 target including viruses and bacteria
Add to my selection

Do you need more information

Simple, comprehensive respiratory testing

The FilmArray Respiratory Panel tests for 17 viruses and 3 bacteria which cause upper respiratory tract infections with an overall sensitivity and specificity of 95% and 99% respectively. It works on the FilmArray™ system, an FDA, CE-IVD, and TGA certified multiplex PCR system. FilmArray™ integrates sample preparation, amplification, detection and analysis into one simple system that requires just 2 minutes of hands-on time, with a total run time of about an hour. Rapid and accurate identification of the causative agent of upper respiratory tract infections may improve patient management by informing timely and effective antibiotic or antiviral therapy, preventing secondary spread of infection, shortening hospital stays and reducing costs of unnecessary ancillary tests.

  • Simple: 2 minutes of hands-on time
  • Easy: No precise measuring or pipetting required
  • Fast: Turnaround time of about an hour
  • Comprehensive: 20 target respiratory panel

20 targets at once

The FilmArray™ Respiratory Panel is incredibly comprehensive, with simultaneous testing for 20 of the most common pathogens involved in UTRI.

Viruses Bacteria
Coronavirus 229E
Coronavirus HKU1
Coronavirus OC43
Coronavirus NL63
Human Metapneumovirus
Human Rhinovirus/Enterovirus
Influenza A
Influenza A/H1
Influenza A/H1-2009
Influenza A/H3
Influenza B
Parainfluenza 1
Parainfluenza 2
Parainfluenza 3
Parainfluenza 4
Bordetella pertussis
Chlamydophila pneumoniae
Mycoplasma pneumoniae


Panel Specification

Sample Handling Performance Parameters
Sample Type: Nasopharyngeal Swab Hands-on time: Approx. 2 minutes
Sample Volume: 300 μL Run turnaround time: About an hour


Clinical Sensitivity and Specificity of the FilmArray Respiratory Pouch

Adenovirus 88.9% 100% 98.3%
Bocavirus 66.7% 100% 99.8%
Coronavirus HKU1 95.8% n/a 99.8%
Coronavirus NL63 95.8% n/a 100%
Coronavirus 229E 100% n/a 99.80%
Coronavirus OC43  100% n/a 99.60%
Human Metapneumovirus 94.6% n/a 99.2%
Human Rhinovirus/Enterovirus 92.7% 95.7% 94.6%
Influenza A 90.0% n/a 99.8%
Influenza A/H1 n/a 100% 100%
Influenza A/H3 n/a 100% 100%
Influenza A/H1-2009 88.9%* 100% 99.6%
Influenza B n/a 100% 100%
Parainfluenza Virus 1 100%* 97.1% 99.9%
Parainfluenza Virus 2 87.4%* 100% 99.8%
Parainfluenza Virus 3 95.8%* 100% 99.8%
Parainfluenza Virus 4 100%* 100% 99.9%
Respiratory Syncytial Virus 100% n/a 89.1%
Bordetella pertussis 100%* 100% 99.90%
Chlamydophila pneumoniae 100%* n/a 100%
Mycoplasma pneumoniae 100%* 90.0% 100%



Fast facts on Respiratory Pathogens

What are Respiratory Pathogens?

The vast majority of respiratory illnesses are caused by viruses and bacteria. In both children and adults, acute respiratory infections  (ARI) are most frequently due to infections with Influenza A and B viruses, Parainfluenza viruses 1, 2 and 3, Respiratory Syncytial Virus (RSV A and B), Adenoviruses and Rhinoviruses. Others pathogens such as Coronaviruses, Bocaviruses, Enteroviruses, Parainfluenza 4, Human Metapneumovirus, Mycoplasma pneumonia and Chlamydophila pneumoniae also infect  the respiratory tract and can cause various diseases from mild self-limiting upper respiratory infections to potentially threatening pneumonia.

Who is most at risk?

Anyone can become infected and ill with these respiratory pathogens. However, young children, the elderly, immunocompromised or weakened individuals (including those with chronic disease, cancer, or in intensive care) are most likely to suffer serious and potentially life-threatening pneumopathies.

What are the benefits of Respiratory pathogens molecular testing?

Clinical symptoms for different respiratory illnesses are similar so in vitro diagnostic molecular methods are necessary to determine the causative agents. Early, rapid and specific detection of the virus or bacteria involved using real-time PCR methods is essential to provide patient-tailored therapy for better outcomes. An accurate diagnosis may also help to control outbreaks, reduce potential antibiotic resistance and facilitate a more rapid patient recovery.



Diagnostics is power